Acupuncture combined with Buyang Huanwu decoction in the treatment of sequelae of cerebrovascular accident: a systematic review and meta-analysis
Journal Title: TMR Non-Drug Therapy - Year 2020, Vol 3, Issue 3
Abstract
Background: Cerebrovascular accident has high morbidity, high disability, and high mortality, possibly causing several serious sequelae and bringing a heavy burden to the patient, the family, and the society. Buyang Huanwu decoction, a classic ancient prescription of traditional Chinese medicine, and acupuncture are often used in combination to treat the sequelae of cerebrovascular accident. In the present study, we systematically evaluated the clinical efficacy and safety of acupuncture combined with Buyang Huanwu decoction in treating the sequelae of cerebrovascular accident. Methods: Relevant randomized controlled trials of acupuncture combined with Buyang Huanwu decoction in treating the sequelae of cerebrovascular accident were comprehensively retrieved from electronic databases from inception to May 8, 2020, including PubMed, Embase, The Cochrane Library, China National Knowledge Infrastructure, WanFang Data, and China Science and Technology Journal Database. The main outcomes of clinical efficacy, degree of nerve function impairment, daily self-care capacity, Fugl-Meyer locomotor function score, life quality score, and occurrence of adverse reactions were subjected to meta-analysis. Results: The 28 randomized controlled trials included 2,341 patients with the sequelae of cerebrovascular accident. Systematic review and meta-analysis indicated that compared with acupuncture alone, its combined treatment with Buyang Huanwu decoction significantly increased clinical efficacy (RR = 1.19, 95% CI (1.14, 1.23), P < 0.001), improved nerve function impairment (WMD = −4.89, 95% CI (−8.25, −1.53), P = 0.004), promoted daily self-care capacity (WMD = 15.87, 95% CI (11.22, 20.51), P < 0.001), strengthened Fugl-Meyer locomotor function (WMD = 20.89, 95% CI (13.79, 27.98), P < 0.001), enhanced physical functioning (WMD = 16.99, 95% CI (6.01, 27.96), P < 0.001) and mental health (WMD = 16.91, 95% CI (9.14, 24.69), P < 0.001) in terms of life quality score (SF-36 scale) of patients with sequelae of cerebrovascular accident, with few adverse reactions. Conclusion: Compared with acupuncture alone, its combination with Buyang Huanwu decoction had better comprehensive effects on sequelae of cerebrovascular accident without obvious adverse reactions.
Authors and Affiliations
Shao-Fu Yu1# ,Yun-Yun Wang2# ,Qi-Yuan He3 ,Lei Zhang3 ,Ying-Hui Jin2 ,Bo-Xuan Liu4 ,Jian-Ping Gong1 ,Li-Ming Tan5*
A series of studies on acupuncture treatment of knee osteoarthritis by Chinese scholars
Knee osteoarthritis (OA) is an important cause of chronic pain and disability in the elderly, affecting 16% of the global population [1–2]. With the increase in life expectancy and the prevalence of obesity, this situati...
Warm-needle acupuncture for limb spasticity post-stroke: a systematic review
Background: Warm acupuncture, or warm-needle acupuncture, is a traditional external treatment widely used in China for thousands of years. However, the effects of different treatment times on limb spasticity post-stroke...
Impact of diabetes education on patients suffering from type 2 diabetes in Saudi Arabia
Background: Diabetes health education is an integral component of diabetes management. The aim of education is not only to provide knowledge and skills, but also to change patients’ attitude and increase motivation towar...
Research progress on the effect of the combination of Jing acupoints bloodletting therapy and Sangzhi (Mori Ramulus) on shoulder-hand syndrome after stroke
Shoulder-hand syndrome (SHS) is one of the common complications of ischemic stroke. The pathogenesis is not completely clear and the therapeutic effects are not very satisfactory. As one of the Five-Shu acupoints (the g...
Neurophysiological basis of auricular acupuncture for the the treatment of p-chlorophenylalanine-induced insomnia
Neurophysiological basis of auricular acupuncture for the the treatment of p-chlorophenylalanine-induced insomnia.